Literature DB >> 26661188

A spatiotemporal theory for MRI T2 relaxation time and apparent diffusion coefficient in the brain during acute ischaemia: Application and validation in a rat acute stroke model.

Michael J Knight1, Bryony L McGarry1, Harriet J Rogers1, Kimmo T Jokivarsi2, Olli H J Gröhn2, Risto A Kauppinen3.   

Abstract

The objective of this study is to present a mathematical model which can describe the spatiotemporal progression of cerebral ischaemia and predict magnetic resonance observables including the apparent diffusion coefficient (ADC) of water and transverse relaxation time T2 This is motivated by the sensitivity of the ADC to the location of cerebral ischaemia and T2 to its time-course, and that it has thus far proven challenging to relate observations of changes in these MR parameters to stroke timing, which is of considerable importance in making treatment choices in clinics. Our mathematical model, called the cytotoxic oedema/dissociation (CED) model, is based on the transit of water from the extra- to the intra-cellular environment (cytotoxic oedema) and concomitant degradation of supramacromolecular and macromolecular structures (such as microtubules and the cytoskeleton). It explains experimental observations of ADC and T2, as well as identifying the rate of spread of effects of ischaemia through a tissue as a dominant system parameter. The model brings the direct extraction of the timing of ischaemic stroke from quantitative MRI closer to reality, as well as providing insight on ischaemia pathology by imaging in general. We anticipate that this may improve patient access to thrombolytic treatment as a future application.
© The Author(s) 2015.

Entities:  

Keywords:  MRI; T2 relaxation; acute ischaemia; apparent diffusion coefficient

Mesh:

Year:  2015        PMID: 26661188      PMCID: PMC4929697          DOI: 10.1177/0271678X15608394

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

1.  Effects of cell volume fraction changes on apparent diffusion in human cells.

Authors:  A W Anderson; J Xie; J Pizzonia; R A Bronen; D D Spencer; J C Gore
Journal:  Magn Reson Imaging       Date:  2000-07       Impact factor: 2.546

Review 2.  Acute and chronic changes of the apparent diffusion coefficient in neurological disorders--biophysical mechanisms and possible underlying histopathology.

Authors:  A Gass; T Niendorf; J G Hirsch
Journal:  J Neurol Sci       Date:  2001-05-01       Impact factor: 3.181

3.  Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy.

Authors:  M E Moseley; Y Cohen; J Mintorovitch; L Chileuitt; H Shimizu; J Kucharczyk; M F Wendland; P R Weinstein
Journal:  Magn Reson Med       Date:  1990-05       Impact factor: 4.668

4.  DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study.

Authors:  Götz Thomalla; Bastian Cheng; Martin Ebinger; Qing Hao; Thomas Tourdias; Ona Wu; Jong S Kim; Lorenz Breuer; Oliver C Singer; Steven Warach; Soren Christensen; Andras Treszl; Nils D Forkert; Ivana Galinovic; Michael Rosenkranz; Tobias Engelhorn; Martin Köhrmann; Matthias Endres; Dong-Wha Kang; Vincent Dousset; A Gregory Sorensen; David S Liebeskind; Jochen B Fiebach; Jens Fiehler; Christian Gerloff
Journal:  Lancet Neurol       Date:  2011-10-04       Impact factor: 44.182

5.  Reduction in water and metabolite apparent diffusion coefficients during energy failure involves cation-dependent mechanisms. A proton nuclear magnetic resonance study of rat cortical brain slices.

Authors:  J M Hakumäki; T R Pirttilä; R A Kauppinen
Journal:  J Cereb Blood Flow Metab       Date:  2000-02       Impact factor: 6.200

6.  Quantitative measurements of relative fluid-attenuated inversion recovery (FLAIR) signal intensities in acute stroke for the prediction of time from symptom onset.

Authors:  Bastian Cheng; Mathias Brinkmann; Nils D Forkert; Andras Treszl; Martin Ebinger; Martin Köhrmann; Ona Wu; Dong-Wha Kang; David S Liebeskind; Thomas Tourdias; Oliver C Singer; Soren Christensen; Marie Luby; Steven Warach; Jens Fiehler; Jochen B Fiebach; Christian Gerloff; Götz Thomalla
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-10       Impact factor: 6.200

7.  Health and infarcted brain tissues studied at short diffusion times: the origins of apparent restriction and the reduction in apparent diffusion coefficient.

Authors:  D G Norris; T Niendorf; D Leibfritz
Journal:  NMR Biomed       Date:  1994-11       Impact factor: 4.044

8.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

9.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

10.  Extracellular volume fraction and diffusion characteristics during progressive ischemia and terminal anoxia in the spinal cord of the rat.

Authors:  E Syková; J Svoboda; J Polák; A Chvátal
Journal:  J Cereb Blood Flow Metab       Date:  1994-03       Impact factor: 6.200

View more
  7 in total

Review 1.  Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach.

Authors:  Laura E Jonkman; Boyd Kenkhuis; Jeroen J G Geurts; Wilma D J van de Berg
Journal:  Neurosci Bull       Date:  2019-02-21       Impact factor: 5.203

2.  Quantifying T 2 relaxation time changes within lesions defined by apparent diffusion coefficient in grey and white matter in acute stroke patients.

Authors:  Robin A Damion; Michael J Knight; Bryony L McGarry; Rose Bosnell; Peter Jezzard; George Wj Harston; Davide Carone; James Kennedy; Salwa El-Tawil; Jennifer Elliot; Keith W Muir; Philip Clatworthy; Risto A Kauppinen
Journal:  Phys Med Biol       Date:  2019-04-29       Impact factor: 3.609

3.  Determining T2 relaxation time and stroke onset relationship in ischaemic stroke within apparent diffusion coefficient-defined lesions. A user-independent method for quantifying the impact of stroke in the human brain.

Authors:  Michael J Knight; Robin A Damion; Bryony L McGarry; Rose Bosnell; Kimmo T Jokivarsi; Olli H J Gröhn; Peter Jezzard; George W J Harston; Davide Carone; James Kennedy; Salwa El-Tawil; Jennifer Elliot; Keith W Muir; Philip Clatworthy; Risto A Kauppinen
Journal:  Biomed Spectrosc Imaging       Date:  2019-07-09

4.  Stroke Onset Time Determination Using MRI Relaxation Times without Non-Ischaemic Reference in A Rat Stroke Model.

Authors:  Terence J T Norton; Marcelo Pereyra; Michael J Knight; Bryony M McGarry; Kimmo T Jokivarsi; Olli H J Gröhn; Risto A Kauppinen
Journal:  Biomed Spectrosc Imaging       Date:  2017-06-20

5.  Multi-parameters of Magnetic Resonance Imaging to Estimate Ischemia-Reperfusion Injury after Stroke in Hyperglycemic Rats.

Authors:  Wei-Yuan Huang; Gang Wu; Shan-Xi Guo; Dao-Ying Geng; Jian-Jun Li; Kai Yang
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

6.  A Comparison of T2 Relaxation-Based MRI Stroke Timing Methods in Hyperacute Ischemic Stroke Patients: A Pilot Study.

Authors:  Bryony L McGarry; Robin A Damion; Isabel Chew; Michael J Knight; George Wj Harston; Davide Carone; Peter Jezzard; Amith Sitaram; Keith W Muir; Philip Clatworthy; Risto A Kauppinen
Journal:  J Cent Nerv Syst Dis       Date:  2020-09-12

7.  Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia.

Authors:  Bryony L McGarry; Kimmo T Jokivarsi; Michael J Knight; Olli H J Grohn; Risto A Kauppinen
Journal:  J Vis Exp       Date:  2017-09-16       Impact factor: 1.355

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.